Microba Life Sciences Limited (MAP.AX)
AUD 0.19
(0.0%)
AUD 0.19
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 16.82 Million AUD | 104.46% |
| 2023 | 8.22 Million AUD | 38.46% |
| 2022 | 5.94 Million AUD | 71.56% |
| 2021 | 3.46 Million AUD | 11.6% |
| 2020 | 3.1 Million AUD | 116.39% |
| 2019 | 1.43 Million AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 15.98 Million AUD | 169.02% |
| 2024 Q4 | 16.82 Million AUD | 0.0% |
| 2024 Q2 | 15.98 Million AUD | 0.0% |
| 2024 FY | 16.36 Million AUD | 98.89% |
| 2023 Q3 | 8.37 Million AUD | 33.34% |
| 2023 FY | 8.22 Million AUD | 38.46% |
| 2023 Q4 | 5.94 Million AUD | -29.07% |
| 2023 Q2 | 6.28 Million AUD | 0.0% |
| 2023 Q1 | 6.28 Million AUD | 7.47% |
| 2022 FY | 5.94 Million AUD | 71.56% |
| 2022 Q4 | 5.84 Million AUD | -1.6% |
| 2022 Q3 | 5.94 Million AUD | 5.48% |
| 2022 Q2 | 5.63 Million AUD | 0.0% |
| 2022 Q1 | 5.63 Million AUD | 62.66% |
| 2021 Q3 | 3.55 Million AUD | 0.0% |
| 2021 FY | 3.46 Million AUD | 11.6% |
| 2021 Q1 | - AUD | 0.0% |
| 2021 Q4 | 3.46 Million AUD | -2.47% |
| 2020 FY | 3.1 Million AUD | 116.39% |
| 2019 FY | 1.43 Million AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Australian Clinical Labs Limited | 415.29 Million AUD | 95.949% |
| BCAL Diagnostics Limited | 3.67 Million AUD | -357.533% |
| Genetic Signatures Limited | 6.18 Million AUD | -172.062% |
| Genetic Technologies Limited | 4.35 Million AUD | -286.223% |
| Healius Limited | 1.94 Billion AUD | 99.134% |
| Imagion Biosystems Limited | 8.37 Million AUD | -100.904% |
| Integral Diagnostics Limited | 442.56 Million AUD | 96.198% |
| INOVIQ Ltd | 1.71 Million AUD | -878.513% |
| Monash IVF Group Limited | 261.81 Million AUD | 93.574% |
| Rhythm Biosciences Limited | 651.54 Thousand AUD | -2482.229% |
| Sonic Healthcare Limited | 6.75 Billion AUD | 99.751% |